Catalyst Clinical Research Overview
- Year Founded
-
2013

- Status
-
Acquired/Merged
- Employees
-
1,000

- Latest Deal Type
-
M&A
- Financing Rounds
-
4
- Investments
-
4
Catalyst Clinical Research General Information
Description
Operator of a full-service, technology-enabled, oncology-focused contract research organization (CRO) intended to serve the biotechnology, pharmaceuticals and medical device companies. The company specializes in a variety of clinical trial services, including multi-therapeutic resourcing and functional solutions as well as operates a niche oncology CRO that helps biotech companies bring next-generation cancer therapies to patients, thereby simplifying clinical research data that can help accelerate the delivery of critical trial decisions, particularly in early-phase.
Contact Information
Website
www.catalystcr.comCorporate Office
- 2528 Independence Boulevard
- Suite 100
- Wilmington, NC 28412
- United States
Corporate Office
- 2528 Independence Boulevard
- Suite 100
- Wilmington, NC 28412
- United States
Catalyst Clinical Research Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Catalyst Clinical Research Comparisons
Industry
Financing
Details
Catalyst Clinical Research Competitors (12)
One of Catalyst Clinical Research’s 12 competitors is IQVIA, a Formerly PE-Backed company based in Durham, NC.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
IQVIA | Formerly PE-Backed | Durham, NC | ||||
Icon (Consulting Services) | Corporation | Dublin, Ireland | ||||
Sofpromed | Corporation | Palma de Mallorca, Spain | ||||
JSS Medical Research | Formerly PE-Backed | Laval, Canada | ||||
Scimega | Corporation | Laval, Canada |
Catalyst Clinical Research Signals
Catalyst Clinical Research Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Catalyst Clinical Research Investments (4)
Catalyst Clinical Research’s most recent deal was a Buyout/LBO with Genpro Research. The deal was made on 20-Jul-2023.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Genpro Research | 20-Jul-2023 | Buyout/LBO | Practice Management (Healthcare) | ||
Aptus Clinical | 01-Apr-2022 | Buyout/LBO | BPO/Outsource Services | ||
Ce3 | 04-Aug-2020 | Buyout/LBO | BPO/Outsource Services | ||
Triangle Biostatistics | 05-Mar-2019 | Buyout/LBO | Other Pharmaceuticals and Biotechnology |
Catalyst Clinical Research Affiliates
Subsidiaries (1)
Name | Industry | Location | Year Founded |
---|---|---|---|
Genpro Research | Waltham, MA | 2016 |
Catalyst Clinical Research FAQs
-
When was Catalyst Clinical Research founded?
Catalyst Clinical Research was founded in 2013.
-
Where is Catalyst Clinical Research headquartered?
Catalyst Clinical Research is headquartered in Wilmington, NC.
-
What is the size of Catalyst Clinical Research?
Catalyst Clinical Research has 1,000 total employees.
-
What industry is Catalyst Clinical Research in?
Catalyst Clinical Research’s primary industry is Other Healthcare Services.
-
Is Catalyst Clinical Research a private or public company?
Catalyst Clinical Research is a Private company.
-
What is Catalyst Clinical Research’s current revenue?
The current revenue for Catalyst Clinical Research is
. -
Who are Catalyst Clinical Research’s investors?
QHP Capital has invested in Catalyst Clinical Research.
-
Who are Catalyst Clinical Research’s competitors?
IQVIA, Icon (Consulting Services), Sofpromed, JSS Medical Research, and Scimega are some of the 12 competitors of Catalyst Clinical Research.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »